GRM5 and psychiatric disorder: As drugs targeting the interaction of GABAB heterodimers have rarely been found, cell-free synthesized GABAB could be used for initial screens targeting neurological and psychiatric disorders by antagonists, such as small peptides35 similar to the antinociceptive bivalent ligand targeting the heteromeric mGlu5-μ-opioid GPCR54.